Prednisolone

製品コードS1737 バッチS173703

印刷

化学情報

 Chemical Structure Synonyms NSC-9900 Storage
(From the date of receipt)
3 years -20°C powder
1 years -80°C in solvent
化学式

C21H28O5

分子量 360.44 CAS No. 50-24-8
Solubility (25°C)* 体外 DMSO 72 mg/mL (199.75 mM)
Ethanol 10 mg/mL (27.74 mM)
Water Insoluble
体内 (毎回新しく調製した物を用意してください)
Homogeneous suspension
CMC-NA
≥5mg/ml Taking the 1 mL working solution as an example, add 5 mg of this product to 1 ml of CMC-Na solution, mix evenly to obtain a homogeneous suspension with a final concentration of 5 mg/ml.
* <1 mg/ml means slightly soluble or insoluble.
* Please note that Selleck tests the solubility of all compounds in-house, and the actual solubility may differ slightly from published values. This is normal and is due to slight batch-to-batch variations.

溶剤液(一定の濃度)を調合する

生物活性

製品説明 Prednisolone is a synthetic glucocorticoid with anti-inflammatory and immunomodulating properties.
in vitro

Prednisolone (50 mg/kg, im) given 15 min before LPS-attenuated production of NO2- and NO3- by neutrophils and suppresses LPS-stimulated mRNA for NOS II in rat neutrophils. [1] This compound reduces joint swelling through a mechanism associated with a reduction in IL-1beta and IL-6 protein and mRNA expression levels in SCW-induced arthritis rats. [2] Its anti-inflammatory effects can be mediated by reducing cellular adhesion molecule (CAM) expression. This compound (0.75 mg/kg) reduces macrophages (-59%, -57%), CD4(+) T-cells (-50%, -60%), CD8(+) T-cells (-58%, -48%), and eosinophils (-36%, -25%) in quadriceps and soleus muscles, respectively. It also exhibits decreased vascular P-selectin (-82%) and ICAM-1 (-52%) expression and fewer L-selectin (-79%) and ICAM-1 (-57%) expressing mononuclear cells in quadriceps. This chemical reduces sarcolemmal damage and degeneration as well in Dystrophin-deficient, mdx mice. [3]

in vivo

Prednisolone (5 mg/kg) causes alterations in diaphragmatic contractile properties and histological changes without fiber atrophy in rats. This compound results in an increased number of diaphragmatic bundles in rats. [4] It induces a significant decline of PL-pO2, while CoBF, CMs, CAPs, and ABRs revealed no change in guinea pigs. [5]

プロトコル(参考用のみ)

参考

  • https://pubmed.ncbi.nlm.nih.gov/7513433/
  • https://pubmed.ncbi.nlm.nih.gov/15196245/
  • https://pubmed.ncbi.nlm.nih.gov/11862126/
  • https://pubmed.ncbi.nlm.nih.gov/8376603/
  • https://pubmed.ncbi.nlm.nih.gov/9472744/

カスタマーフィードバック

, , PLoS One, 2014, 9(12):e111840.

Data from [Data independently produced by , , Leuk Lymphoma, 2014, 55(5):1144-50. ]

Selleckの高級品が、幾つかの出版された研究調査結果(以下を含む)で使われた:

KAT/3BP: A Metabolism-Targeting Agent with Single and Combination Activity in Aggressive B-Cell Lymphomas [ Cancers (Basel), 2025, 17(12)2034] PubMed: 40563683
Leveraging automated time-lapse microscopy coupled with deep learning to automate colony forming assay [ Front Oncol, 2025, 15:1520972] PubMed: 40046624
Channel Expansion in the Ligand-Binding Domain of the Glucocorticoid Receptor Contributes to the Activity of Highly Potent Glucocorticoid Analogues [ Molecules, 2024, 29(7)1546] PubMed: 38611825
PRMT5 triggers glucocorticoid-induced cell migration in triple-negative breast cancer [ Life Sci Alliance, 2023, 6(10)e202302009] PubMed: 37536978
PRMT5 triggers glucocorticoid-induced cell migration in triple-negative breast cancer [ Life Sci Alliance, 2023, 6(10)e202302009] PubMed: 37536978
Reversal of IKZF1-induced glucocorticoid resistance by dual targeting of AKT and ERK signaling pathways [ Front Oncol, 2022, 12:905665] PubMed: 36119546
Application of a newly-developed cynomolgus macaque BiTE-mediated cytotoxic T-lymphocyte activity assay to various immunomodulatory agents in vitro [ J Immunotoxicol, 2021, 18(1):154-162] PubMed: 34714999
In vitro effect of biological and conventional disease-modifying antirheumatic drugs on fibrocyte differentiation in patients with rheumatoid arthritis and healthy controls [ Eur J Rheumatol, 2021, 10.5152/eurjrheum.2021.20054] PubMed: 34059186
Glucocorticoids improve severe or critical COVID-19 by activating ACE2 and reducing IL-6 levels [ Int J Biol Sci, 2020, 16(13):2382-2391] PubMed: 32760206
WEE1 inhibition synergizes with CHOP chemotherapy and radiation therapy through induction of premature mitotic entry and DNA damage in diffuse large B-cell lymphoma [ Ther Adv Hematol, 2020, 11:2040620719898373] PubMed: 32010435

長期の保管のために-20°Cの下で製品を保ってください。

人間や獣医の診断であるか治療的な使用のためにでない。

各々の製品のための特定の保管と取扱い情報は、製品データシートの上で示されます。大部分のSelleck製品は、推薦された状況の下で安定です。製品は、推薦された保管温度と異なる温度で、時々出荷されます。長期の保管のために必要とされてそれと異なる温度で、多くの製品は、短期もので安定です。品質を維持するが、夜通しの積荷のために最も経済的な貯蔵状況を用いてあなたの送料を保存する状況の下に、製品が出荷されることを、我々は確実とします。製品の受領と同時に、製品データシートの上で貯蔵推薦に従ってください。